Diagnostic Platforms for Lung Cancer

February 24, 2015
Maria E. Arcila, MD

Special Reports, NSCLC (Issue 6), Volume 6, Issue 1

Maria E. Arcila, MD, acting director, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, discusses diagnostic platforms for lung cancer.

Maria E. Arcila, MD, acting director, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, discusses diagnostic platforms for lung cancer.

<<<

View more from the NSCLC Special Report